|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$456,868
|
$456,868
|
Barchi, Joseph
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus
|
ZIA BC 011528
|
$17,654
|
$17,654
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,360,387
|
$68,019
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Androgen Receptor in Bladder Cancer
|
ZIA BC 011527
|
$44,135
|
$44,135
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Applied Molecular Pathology Laboratory
|
ZIC BC 011257
|
$158,649
|
$6,346
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,704,173
|
$735,209
|
Custer, Mary
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$709,489
|
$70,949
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$368,848
|
$258,194
|
Buck, Christopher
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$176,965
|
$176,965
|
Apolo, Andrea
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$7,799
|
$3,899
|
Kong, Heidi
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,097,105
|
$109,710
|
Restifo, Nicholas
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$848,869
|
$169,774
|
Dean, Michael
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$531,398
|
$53,140
|
Garfield, Susan
|
CCR (NCI)
|
|
Characterization of the interaction between inflammation and cancer progression
|
ZIA BC 010892
|
$272,831
|
$136,416
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$231,139
|
$115,570
|
Pinto, Peter
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$760,245
|
$456,147
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$389,472
|
$19,474
|
Feldman, Steven
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$506,830
|
$380,122
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$93,272
|
$23,318
|
Bates, Susan
|
CCR (NCI)
|
|
Comparison of molecular factors to drug activities.
|
ZIC BC 011509
|
$62,413
|
$6,241
|
Reinhold, William
|
CCR (NCI)
|
|
Computer-Aided Detection of Urinary Tract Cancer on MDCT Urography
|
5R01CA134688-05
|
$353,464
|
$176,732
|
HADJIYSKI, LUBOMIR
|
UNIVERSITY OF MICHIGAN
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,138,166
|
$1,138,166
|
Young, Howard
|
CCR (NCI)
|
|
Contribution of Y-specific Genes to Bladder Cancer
|
ZIA BC 011591
|
$176,541
|
$176,541
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$797,143
|
$159,429
|
Meier, Jordan
|
CCR (NCI)
|
|
Development and use of nanoFACS for analysis and sorting of nanoparticles
|
ZIA BC 011502
|
$294,534
|
$14,727
|
Jones, Jennifer
|
CCR (NCI)
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011349
|
$391,468
|
$19,573
|
Pack, Svetlana
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$77,067
|
$7,707
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$238,328
|
$71,498
|
Beutler, John
|
CCR (NCI)
|
|
DNA Sequencing and FACS Core Facilities
|
ZIC BC 010948
|
$1,672,040
|
$83,602
|
Robbins, Paul
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a Novel Tumor Suppressor
|
ZIA BC 011592
|
$114,752
|
$114,752
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$43,373
|
N/A
|
National Institutes of Health
|
|
Families at high risk of cancer
|
ZIA CP004410 - 08285
|
$1,009,947
|
$100,995
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$1,037,081
|
$207,416
|
Yang, James
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$333,231
|
$6,665
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetics of Complex Diseases and Health Disparities
|
ZIA BC 010022
|
$476,229
|
$476,229
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Genomics and Bioinformatics Group web site development and maintenance.
|
ZIC BC 011475
|
$166,434
|
$33,287
|
Reinhold, William
|
CCR (NCI)
|
|
Growth/Differentiation Factors in Organogenesis
|
ZIA BC 005093
|
$822,793
|
$740,514
|
Perantoni, Alan
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$88,271
|
$88,271
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,176,083
|
$58,804
|
Kleiner, David
|
CCR (NCI)
|
|
Identification of Genetic Factors Associated with Infectious Diseases
|
ZIA BC 010297
|
$317,486
|
$63,497
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$102,756
|
$102,756
|
Bottaro, Donald
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$787,265
|
$39,363
|
Khan, Javed
|
CCR (NCI)
|
|
Immunophysiological Mechanisms in the Biological Therapy of Cancer
|
ZIA BC 009262
|
$545,663
|
$272,831
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,151,994
|
$575,997
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Investigation of Epigentic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$44,135
|
$44,135
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$139,909
|
$27,982
|
Bates, Susan
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$999,694
|
$49,985
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,436,451
|
$443,645
|
Gulley, James
|
CCR (NCI)
|
|
Metabolic Mechanisms for Programmed Cell Death
|
ZIA BC 010743
|
$285,197
|
$114,079
|
Phang, James
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$141,951
|
$141,951
|
Merino, Maria
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $16,026,237
|